금융 뉴스 허브

BoE: Softer labour market data shape rate path – Nomura

Nomura’s Josie Anderson, George Buckley, Andrzej Szczepaniak and David Seif highlight a softer UK labour market, with falling payrolls, rising unemployment and weaker vacancies. They stress that labou ...

Australia Turns to China for Emergency Jet Fuel Supplies

Australia has secured three shipments of jet fuel from China, and more are expected in the coming months as Australia is scrambling to ensure its fuel supply amid the global crunch, and one of its onl ...

Investors are piling into U.S. equity funds at the fastest pace in years. But now the pendulum may swing back, warns Barclays

Funds are fully invested and so the risk of a pullback has increased

Nasdaq futures lead declines as tech pressure persists

3 Reasons to Avoid IFF and 1 Stock to Buy Instead

International Flavors & Fragrances has had an impressive run over the past six months as its shares have beaten the S&P 500 by 5.5%. The stock now trades at $76.21, marking a 17% gain. This was partly ...

Hesai Group beats top-line and bottom-line estimates; initiates Q2 outlook

Dow Jones futures maintain position as Trump calls off Iran attack

Dow Jones futures inch higher by 0.05% to near 49,800 during the European hours ahead of the United States (US) regular opening on Tuesday. Meanwhile, the S&P 500 gain 0.07% to near 7,430, and the Nas ...

Euro gives away gains amid geopolitical uncertainty, rising Oil prices

The Euro (EUR) resumes its bearish trend against the US Dollar (USD) on Tuesday, retreating to levels near 1.1630 at the time of writing, from Monday’s highs right above 1.1660.

Archer GAAP EPS of $0.04, revenue of $278.4M

Japanese Yen: Strong GDP fails to lift versus US Dollar – Deutsche Bank

Deutsche Bank analysts note Japan’s economy grew faster than expected in Q1 2026, supporting the case for further Bank of Japan (BoJ) rate hikes, yet the Japanese Yen (JPY) weakened slightly against t ...

Avacta Group GAAP EPS of -9.27p; gives FY outlook

2 Reasons to Like ABBV and 1 to Stay Skeptical

Over the past six months, AbbVie’s shares (currently trading at $211.15) have posted a disappointing 9.8% loss, well below the S&P 500’s 11.5% gain. This might have investors contemplating their next ...